Endo Greg bought VLCN
July 17, 2025 · Form 4 insider transaction
Endo Greg bought 747,005 shares of VLCN, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
The stock options were issued by the Issuer in connection with the Reporting Person's employment service as Chief Financial Officer of the Issuer on July 17, 2025. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan.; The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan.